AFP and cancer: In a routine health examination of 56,286 people aged 13–86 years, Sven Skog et al. found that TK1 was more sensitive than CEA and AFP in detecting malignant tumors, and about 30% more sensitivity was achieved with a combination of TK1, CEA, and AFP [49].